Advisory Council on Alzheimer's Research, Care, and Services; Meeting, 81551 [2015-32890]

Download as PDF mstockstill on DSK4VPTVN1PROD with NOTICES Federal Register / Vol. 80, No. 250 / Wednesday, December 30, 2015 / Notices determine whether their food products are subject to these regulations by providing for voluntary submission of process filings by processors of nonacidified foods (e.g., some acid foods or fermented foods), and by helping processors of acidified foods in ensuring safe manufacturing, processing, and packing processes and in employing appropriate quality control procedures. We are withdrawing the draft guidance, in part, because many of the topics addressed in the draft guidance are now being addressed in other documents. DATES: The withdrawal is effective December 30, 2015. FOR FURTHER INFORMATION CONTACT: Michael Mignogna, Center for Food Safety and Applied Nutrition (HFS– 302), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, 240–402–1565. SUPPLEMENTARY INFORMATION: In a notice published in the Federal Register of September 27, 2010 (75 FR 59268), we announced the availability of a draft guidance entitled ‘‘Draft Guidance for Industry: Acidified Foods’’ and gave interested parties an opportunity to submit comments by December 27, 2010, for us to consider before beginning work on the final version of the guidance. The draft guidance was intended to complement our regulations regarding acidified foods (including regulations for specific current good manufacturing practice (21 CFR part 114), establishment registration (21 CFR 108.25(c)(1)), and process filing (21 CFR 108.25(c)(2)) by helping commercial food processors in determining whether their food products are subject to these regulations and by providing for voluntary submission of process filings by processors who conclude that their products are non-acidified foods (e.g., acid foods or fermented foods). The draft guidance also was intended to help processors of acidified foods in ensuring safe manufacturing, processing, and packing processes and in employing appropriate quality control procedures. We are withdrawing the draft guidance, in part, because the procedures for voluntary submission of process filings by processors of nonacidified foods are addressed by our recently issued guidance entitled ‘‘Submitting Form FDA 2541 (Food Canning Establishment Registration) and Forms FDA 2541d, FDA 2541e, FDA 2541f, and FDA 2541g (Food Process Filing Forms) to FDA in Electronic or Paper Format’’ (80 FR 60909, October 8, 2015). We also are withdrawing the draft guidance, in part, because we recently issued a final rule entitled ‘‘Current Good Manufacturing VerDate Sep<11>2014 17:59 Dec 29, 2015 Jkt 238001 Practice, Hazard Analysis, and RiskBased Preventive Controls for Human Food’’ (80 FR 55908, September 17, 2015), and that rule, along with guidance documents we are developing as a companion to that rule, should help processors in ensuring safe manufacturing, processing, and packing processes and in employing appropriate quality control procedures. Dated: December 23, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–32781 Filed 12–29–15; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Advisory Council on Alzheimer’s Research, Care, and Services; Meeting Assistant Secretary for Planning and Evaluation, HHS. ACTION: Notice of meeting. AGENCY: This notice announces the public meeting of the Advisory Council on Alzheimer’s Research, Care, and Services (Advisory Council). The Advisory Council on Alzheimer’s Research, Care, and Services provides advice on how to prevent or reduce the burden of Alzheimer’s disease and related dementias on people with the disease and their caregivers. During the January meeting, the Advisory Council will review the process for developing recommendations and developing the National Plan to Address Alzheimer’s Disease, discuss updates to work on Goals 2 and 3 of the National Plan, and hear updates on a future summit on care. DATES: The meeting will be held on January 25, 2016 from 9:30 a.m. to 5:00 p.m. EDT. ADDRESSES: The meeting will be held in Room 6, Building 31 of the National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892. Comments: Time is allocated in the afternoon on the agenda to hear public comments. The time for oral comments will be limited to two (2) minutes per individual. In lieu of oral comments, formal written comments may be submitted for the record to Rohini Khillan, ASPE, 200 Independence Avenue SW., Room 424E, Washington, DC 20201. Comments may also be sent to napa@hhs.gov. Those submitting written comments should identify themselves and any relevant organizational affiliations. FOR FURTHER INFORMATION CONTACT: Rohini Khillan (202) 690–5932, SUMMARY: PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 81551 rohini.khillan@hhs.gov. Note: Seating may be limited. Those wishing to attend the meeting must send an email to napa@hhs.gov and put ‘‘January 25 Meeting Attendance’’ in the Subject line by Friday, January 15, so that their names may be put on a list of expected attendees and forwarded to the security officers at the National Institutes of Health. Any interested member of the public who is a non-U.S. citizen should include this information at the time of registration to ensure that the appropriate security procedure to gain entry to the building is carried out. Although the meeting is open to the public, procedures governing security and the entrance to Federal buildings may change without notice. If you wish to make a public comment, you must note that within your email. SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)). Topics of the Meeting: During the January meeting, the Advisory Council will review the process for developing recommendations and developing the National Plan to Address Alzheimer’s Disease, discuss updates to work on Goals 2 and 3 of the National Plan, and hear updates on a future summit on care. Procedure and Agenda: This meeting is open to the public. Please allow 45 minutes to go through security and walk to the meeting room. The meeting will also be webcast at www.hhs.gov/live. Authority: 42 U.S.C. 11225; Section 2(e)(3) of the National Alzheimer’s Project Act. The panel is governed by provisions of Public Law 92–463, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. Dated: December 21, 2015. Richard G. Frank, Assistant Secretary for Planning and Evaluation. [FR Doc. 2015–32890 Filed 12–29–15; 8:45 am] BILLING CODE 4150–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. E:\FR\FM\30DEN1.SGM 30DEN1

Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 80, Number 250 (Wednesday, December 30, 2015)]
[Notices]
[Page 81551]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-32890]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Advisory Council on Alzheimer's Research, Care, and Services; 
Meeting

AGENCY: Assistant Secretary for Planning and Evaluation, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces the public meeting of the Advisory 
Council on Alzheimer's Research, Care, and Services (Advisory Council). 
The Advisory Council on Alzheimer's Research, Care, and Services 
provides advice on how to prevent or reduce the burden of Alzheimer's 
disease and related dementias on people with the disease and their 
caregivers. During the January meeting, the Advisory Council will 
review the process for developing recommendations and developing the 
National Plan to Address Alzheimer's Disease, discuss updates to work 
on Goals 2 and 3 of the National Plan, and hear updates on a future 
summit on care.

DATES: The meeting will be held on January 25, 2016 from 9:30 a.m. to 
5:00 p.m. EDT.

ADDRESSES: The meeting will be held in Room 6, Building 31 of the 
National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 
20892.
    Comments: Time is allocated in the afternoon on the agenda to hear 
public comments. The time for oral comments will be limited to two (2) 
minutes per individual. In lieu of oral comments, formal written 
comments may be submitted for the record to Rohini Khillan, ASPE, 200 
Independence Avenue SW., Room 424E, Washington, DC 20201. Comments may 
also be sent to napa@hhs.gov. Those submitting written comments should 
identify themselves and any relevant organizational affiliations.

FOR FURTHER INFORMATION CONTACT: Rohini Khillan (202) 690-5932, 
rohini.khillan@hhs.gov. Note: Seating may be limited. Those wishing to 
attend the meeting must send an email to napa@hhs.gov and put ``January 
25 Meeting Attendance'' in the Subject line by Friday, January 15, so 
that their names may be put on a list of expected attendees and 
forwarded to the security officers at the National Institutes of 
Health. Any interested member of the public who is a non-U.S. citizen 
should include this information at the time of registration to ensure 
that the appropriate security procedure to gain entry to the building 
is carried out. Although the meeting is open to the public, procedures 
governing security and the entrance to Federal buildings may change 
without notice. If you wish to make a public comment, you must note 
that within your email.

SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the 
Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and 
(a)(2)). Topics of the Meeting:
    During the January meeting, the Advisory Council will review the 
process for developing recommendations and developing the National Plan 
to Address Alzheimer's Disease, discuss updates to work on Goals 2 and 
3 of the National Plan, and hear updates on a future summit on care.
    Procedure and Agenda: This meeting is open to the public. Please 
allow 45 minutes to go through security and walk to the meeting room. 
The meeting will also be webcast at www.hhs.gov/live.
    Authority: 42 U.S.C. 11225; Section 2(e)(3) of the National 
Alzheimer's Project Act. The panel is governed by provisions of Public 
Law 92-463, as amended (5 U.S.C. Appendix 2), which sets forth 
standards for the formation and use of advisory committees.

    Dated: December 21, 2015.
Richard G. Frank,
Assistant Secretary for Planning and Evaluation.
[FR Doc. 2015-32890 Filed 12-29-15; 8:45 am]
BILLING CODE 4150-05-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.